Patent · US Active

Anti-FGFR2/3 antibodies and methods using same

US10208120B2 · kind B2 · utility

0Cited by
82References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2015
Grant dateFeb 19, 2019
Priority date—
Expiry dateMar 14, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides dual specific anti-FGFR2 and FGFR3 (FGFR2/3) antibodies, and compositions comprising and methods of using these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.